GlyRS-IN-1
GlyRS-IN-1 is a glycyl-tRNA synthase (GlyRS) inhibitor extracted from patent WO 2017066459 A1. GlyRS-IN-1 can also inhibit the growth of bacteria[1].
Product Specifications
CAS Number
[112921-11-6]
UNSPSC
12352005
Target
Aminoacyl-tRNA Synthetase; Bacterial
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/GlyRS-IN-1.html
Purity
99.40
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=C2N=CN([C@@H]([C@H](O)[C@@H]3O)O[C@@H]3COS(=O)(NC(CN)=O)=O)C2=NC=N1
Molecular Formula
C12H17N7O7S
Molecular Weight
403.37
References & Citations
[1]Xiang-Lei Yang, et al. INHIBITION OF NEDDYLATION USING GLYCYL-tRNA SYNTHETASE INHIBITORS. WO 2017066459 A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SAR1A (GTP-binding Protein SAR1a, COPII-associated Small GTPase, Masra2, SAR1, SARA, SARA1) (MaxLight 750) discontinued
